14-day Premium Trial Subscription Try For FreeGet Free
$113.02
+0.85 (+0.758%)
At Close: Nov 27, 2023
Chart & Forecast Earnings Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Nov 16, 2023 Sell 2 750 Sherwin Stephen A Common Stock
Oct 02, 2023 Sell 1 437 Boyer David W. Common Stock
Sep 12, 2023 Buy 5 000 Lyons Gary A Common Stock
Sep 12, 2023 Sell 5 000 Lyons Gary A Common Stock
Sep 12, 2023 Sell 5 000 Lyons Gary A Non-Qualified Stock Option
Sep 01, 2023 Buy 5 000 Lyons Gary A Common Stock
Sep 01, 2023 Sell 5 000 Lyons Gary A Common Stock
Sep 01, 2023 Sell 5 000 Lyons Gary A Non-Qualified Stock Option
Sep 01, 2023 Sell 824 Cooke Julie Common Stock
Aug 30, 2023 Sell 1 295 Boyer David W. Common Stock
Aug 30, 2023 Sell 1 438 Boyer David W. Common Stock
Aug 30, 2023 Sell 190 Lippoldt Darin Common Stock
Aug 28, 2023 Sell 1 431 Delaet Ingrid Common Stock
Aug 21, 2023 Sell 3 198 Roberts Eiry Common Stock
Aug 21, 2023 Sell 3 198 Onyia Jude Common Stock
Aug 21, 2023 Sell 2 132 Lippoldt Darin Common Stock
Aug 21, 2023 Sell 9 328 Gorman Kevin Charles Common Stock
Aug 21, 2023 Sell 2 132 Gano Kyle Common Stock
Aug 21, 2023 Sell 1 404 Delaet Ingrid Common Stock
Aug 21, 2023 Sell 2 132 Cooke Julie Common Stock
Aug 21, 2023 Sell 1 600 Boyer David W. Common Stock
Aug 21, 2023 Sell 1 600 Benevich Eric Common Stock
Aug 21, 2023 Sell 2 132 Abernethy Matt Common Stock
Jul 11, 2023 Buy 16 375 Poon Christine A Non-Qualified Stock Option
Jul 11, 2023 Buy 0 Poon Christine A
May 17, 2023 Buy 4 199 Sherwin Stephen A Restricted Stock Unit
May 17, 2023 Buy 4 290 Sharp Shalini Non-Qualified Stock Option
May 17, 2023 Buy 2 100 Sharp Shalini Restricted Stock Unit
May 17, 2023 Buy 8 579 Rastetter William H Non-Qualified Stock Option
May 17, 2023 Buy 4 199 Pops Richard F Restricted Stock Unit
May 17, 2023 Buy 4 290 Norwalk Leslie V Non-Qualified Stock Option
May 17, 2023 Buy 2 100 Norwalk Leslie V Restricted Stock Unit
May 17, 2023 Buy 4 199 Morrow George J Restricted Stock Unit
May 17, 2023 Buy 4 290 Mercier Johanna Non-Qualified Stock Option
May 17, 2023 Buy 2 100 Mercier Johanna Restricted Stock Unit
May 17, 2023 Buy 4 290 Lyons Gary A Non-Qualified Stock Option
May 17, 2023 Buy 2 100 Lyons Gary A Restricted Stock Unit
Nov 02, 2020 Buy 0 Benevich Eric
Jun 01, 2018 Buy 0 Benevich Eric
Nov 12, 2020 Buy 0 Lippoldt Darin
May 01, 2023 Buy 7 625 Rastetter William H Common Stock
May 01, 2023 Sell 4 300 Rastetter William H Common Stock
May 01, 2023 Sell 7 625 Rastetter William H Non-Qualified Stock Option
May 01, 2023 Sell 11 397 Cooke Julie Common Stock
Oct 02, 2020 Buy 0 Cooke Julie
Apr 25, 2023 Sell 100 Cooke Julie Common Stock
Apr 24, 2023 Sell 14 400 Roberts Eiry Common Stock
Nov 12, 2020 Buy 0 Roberts Eiry
Apr 21, 2023 Buy 10 765 Rastetter William H Common Stock
Apr 21, 2023 Sell 6 034 Rastetter William H Common Stock
Apr 19, 2023 Buy 1 610 Rastetter William H Common Stock
Apr 19, 2023 Sell 903 Rastetter William H Common Stock
Apr 19, 2023 Sell 1 610 Rastetter William H Non-Qualified Stock Option
Apr 21, 2023 Sell 10 765 Rastetter William H Non-Qualified Stock Option
Feb 23, 2023 Buy 4 395 588 Neurocrine Biosciences Inc Common Stock
Feb 13, 2023 Buy 33 771 Delaet Ingrid Stock Option
Feb 13, 2023 Buy 5 434 Delaet Ingrid Restricted Stock Unit
Feb 09, 2023 Buy 0 Delaet Ingrid Common Stock
Feb 09, 2023 Buy 3 359 Delaet Ingrid Incentive Stock Option
Feb 09, 2023 Buy 9 367 Delaet Ingrid Non-Qualified Stock Option
Feb 09, 2023 Buy 827 Delaet Ingrid Incentive Stock Option
Feb 09, 2023 Buy 12 261 Delaet Ingrid Non-Qualified Stock Option
Feb 09, 2023 Buy 5 435 Delaet Ingrid Restricted Stock Unit
Feb 09, 2023 Buy 3 202 Delaet Ingrid Restriced Stock Unit
Feb 13, 2023 Buy 52 532 Roberts Eiry Stock Option
Feb 13, 2023 Buy 8 453 Roberts Eiry Restricted Stock Unit
Feb 13, 2023 Buy 67 541 Onyia Jude Stock Option
Feb 13, 2023 Buy 10 868 Onyia Jude Restricted Stock Unit
Feb 13, 2023 Buy 51 782 Lippoldt Darin Stock Option
Feb 13, 2023 Buy 8 332 Lippoldt Darin Restricted Stock Unit
Feb 13, 2023 Buy 133 656 Gorman Kevin Charles Stock Option
Feb 13, 2023 Buy 21 506 Gorman Kevin Charles Restricted Stock Unit
Feb 13, 2023 Buy 63 789 Gano Kyle Stock Option
Feb 13, 2023 Buy 10 264 Gano Kyle Restricted Stock Unit
Feb 13, 2023 Buy 37 523 Cooke Julie Stock Option
Feb 13, 2023 Buy 6 038 Cooke Julie Restricted Stock Unit
Feb 13, 2023 Buy 45 027 Boyer David W. Stock Option
Feb 13, 2023 Buy 7 245 Boyer David W. Restricted Stock Unit
Feb 13, 2023 Buy 51 782 Benevich Eric Stock Option
Feb 13, 2023 Buy 8 332 Benevich Eric Restricted Stock Unit
Feb 13, 2023 Buy 63 789 Abernethy Matt Stock Option
Feb 13, 2023 Buy 10 264 Abernethy Matt Restricted Stock Unit
Feb 07, 2023 Sell 12 801 Cooke Julie Common Stock
Feb 08, 2023 Sell 700 Cooke Julie Common Stock
Feb 08, 2023 Sell 628 Cooke Julie Common Stock
Feb 07, 2023 Sell 822 Cooke Julie Common Stock
Feb 07, 2023 Sell 913 Cooke Julie Common Stock
Feb 06, 2023 Sell 640 Cooke Julie Common Stock
Feb 06, 2023 Sell 575 Cooke Julie Common Stock
Feb 08, 2023 Sell 980 Roberts Eiry Common Stock
Feb 07, 2023 Sell 12 801 Roberts Eiry Common Stock
Feb 07, 2023 Sell 1 623 Roberts Eiry Common Stock
Feb 06, 2023 Sell 1 121 Roberts Eiry Common Stock
Feb 07, 2023 Sell 4 508 Onyia Jude Common Stock
Feb 08, 2023 Sell 701 Lloyd-smith Malcolm Common Stock
Feb 07, 2023 Sell 12 801 Lloyd-smith Malcolm Common Stock
Feb 07, 2023 Sell 1 015 Lloyd-smith Malcolm Common Stock
Feb 06, 2023 Sell 801 Lloyd-smith Malcolm Common Stock
Feb 08, 2023 Sell 911 Lippoldt Darin Common Stock
Feb 07, 2023 Sell 12 801 Lippoldt Darin Common Stock
INSIDER POWER
90.665
Last 100 transactions
Buy: 5 221 078 | Sell: 182 497 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 90.665.

In total, the insiders bought 5 221 078 and sold 182 497 NBIX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Neurocrine Biosciences

Neurocrine Biosciences Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The company's commercial products include ON... NBIX Profile

Golden Star

Ticker Date Change Price
IEX Nov 22 0.684% $197.25
Z Nov 22 3.37% $39.76
LXP Nov 21 2.63% $8.35
RLI Nov 20 3.82% $134.51
TAP Nov 20 2.10% $59.00
DINO Nov 20 0.203% $54.25
LPLA Nov 20 2.44% $225.11
EHC Nov 15 1.92% $63.90
CSX Nov 13 4.89% $30.45
SNX Nov 13 4.17% $94.57
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT